Please use this identifier to cite or link to this item: http://cris.unibe.edu.do/handle/123456789/378
Title: SARS-CoV-2 variants distribution and infections in vaccinated and unvaccinated hospitalized individuals in the Dominican Republic
Autores: Paulino-Ramírez, Robert
Rojas-Fermín, R.
Cuevas Martínez, Paula
Tapia-Barredo, Leandro
Vallejo Degaudenzi, A.
Mueses Jiménez, Sayira P.
Virgilio Calderón, V.
Jabier Frías, Maridania
Guzmán-Marte, A.
Tolari-Jacobo, G.
Ruiz De León, Ingrid C.
Sánchez-Marmolejos, A.
Cuevas Lantigua, G.
Researchers (UNIBE): Paulino-Ramírez, Robert 
Cuevas Martínez, Paula 
Tapia-Barredo, Leandro 
Mueses Jiménez, Sayira P. 
Jabier Frías, Maridania 
Ruiz De León, Ingrid C. 
Affiliations: Instituto de Medicina Tropical y Salud Global (IMTSAG) 
Instituto de Medicina Tropical y Salud Global (IMTSAG) 
Instituto de Medicina Tropical y Salud Global (IMTSAG) 
Instituto de Medicina Tropical y Salud Global (IMTSAG) 
Instituto de Medicina Tropical y Salud Global (IMTSAG) 
Instituto de Medicina Tropical y Salud Global (IMTSAG) 
Research area: Ciencias de la Salud
Issue Date: 2023
Publisher: Sociedade Regional de Ensino e Saúde
Source: InterAmerican Journal of Medicine and Health, 5, 1–19; 2023
Journal: InterAmerican Journal of Medicine and Health 
Volume: 5
Start page: 1
End page: 19
Abstract: 
First cases of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the Dominican Republic (DR) were reported in early 2020. During the first trimester of 2021 a national vaccination campaign was deployed, including whole-virus inactivated, adenovirus-based, and mRNA vaccines platforms. To better understand the effectiveness and efficiency of vaccines to reduce COVID-19 related deaths, among vaccinated (2-doses), unvaccinated and partially vaccinated (1-doses), and SARS-CoV-2 variants we analyzed clinical and molecular data obtained from breakthrough infections in hospitalized individuals. Samples from SARS-CoV-2 infected hospitalized patients were collected for viral sequencing. During the study period, we analyzed the data of thirty-three (n=33) COVID-19 case-patients from June to September 2021. Studied cases reported receiving a whole-virus attenuated vaccine (CoronaVac) in 36.8%. The survival rate among two-dose vaccinated individuals was 73% (95% CI, 70.8 to 74.2) compared to 65% in unvaccinated individuals. Molecular variant analysis of variant circulation among infections was initially due to B.1.621 (Mu) and rapidly shifting to B.1.617 (Delta) variants. No differences in outcomes between Mu, Iota, or Delta infections were observed. This suggests that VOIs can also have a deleterious impact on vaccinated individuals.
URI: http://cris.unibe.edu.do/handle/123456789/378
DOI: 10.31005/iajmh.v5i.244
Appears in Collections:Publicaciones del IMTSAG-UNIBE

Files in This Item:
File Description SizeFormat
244+-+Manuscript+Vaccines+and+Variants+Text+IJMH.pdfPre-Publication release of accepted article495.98 kBAdobe PDFView/Open
Show full item record Recommend this item

Google ScholarTM

Citations

Altmetric

Mentions

Dimensions

Citations


This item is licensed under a Creative Commons License Creative Commons